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The Dangers of Fat Metabolism and PUFA: Why You Don’t Want to be a “Fat 
Burner”  
Introduction 
 Low carbohydrate dieting (low carb) is popular in the paleo and ancestral diet communities.  The scientific literature on the merits of this diet, however, remains contested. Examples of clinical studies showing benefits for weight loss [1] and metabolic syndrome [2] are easy to find. Likewise, studies showing negative effects, such as on exercise performance [3], also continue to be published as valid criticisms of claims made by the diet’s adherents. A meta-analysis of weight loss trials suggests that low carb dieting is as or more effective than low-fat for up to one year, at which point results converge [4]. Most clinical studies do not extend to one year, let alone the decade or more that would constitute evidence of long term effects. Furthermore, even if a low carb diet does produce more rapid weight loss than other dieting regimens, it does not necessarily follow that it is healthy; several unhealthy states can cause weight loss.  These points underpin the faulty approach of using clinical studies to answer the 
question of whether low carb is “good” or “bad.” This reduces the debate to a back and forth of dueling studies. Rather than argue a side with macro-level data, I will present a discussion on the physiology of the metabolic state achieved from a low carb diet. The discussion is in three parts, 1) acquisition of a fat-burning metabolism, 2) the long-term physiology associated with this state and 3) health implications specific to the polyunsaturated fatty acids (PUFA).   
1) Entering the fat-burning state  The biochemical processes that mobilize stored and dietary fat for use as energy substrate are initiated due to a depletion of blood glucose. The key hormonal switches involved, adrenal glucocorticoids [5] and catecholamines [6], are secreted as a hypoglycemic response. These hormones are also secreted in response to fasting [7]. Unlike the reciprocity seen in the control of glucose usage by insulin [8], which is secreted as a reaction to glucose, the hormones that control fatty acid utilization are regulated by glucose, not fatty acids. This, in addition to the similarity of the hormone profile between starvation/fasting and consuming a ketogenic, very low carb diet, suggests that glucose sparing and reliance on fat as a primary energy source is the emergency, not the homeostatic, program for humans.  Another point of evidence for this view is that protein, both dietary [9] and tissue [10], is catabolized for production of glucose during hypoglycemia. This source of glucose is sufficient to prevent ketosis during carbohydrate restriction, provided a high enough protein intake [11]. For non-ketotic low carb dieting, this energy substrate production may account for much of the observed weight loss; the process of gluconeogenesis from amino acids costs approximately 33% of the energy 
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obtained in the oxidation of the resulting glucose [12]. Additionally,if the saturable urea system [13] is overwhelmed by amino acid derived ammonia, symptoms of 
hyperammonemia, or “rabbit starvation,” follow [14]. Even at a subclinical level, greater ammonia is a burden on kidney nephrons [15,16].   
2) The long-term physiology associated with fat burning  Once a fat burning state is achieved, loosely defined hormonally as lower insulin and higher glucagon, cortisol and catecholamines, other changes begin to assert themselves that integrate into the overall low-level stress state. One of these changes is a depression of the respiratory quotient, as less carbon dioxide (CO2) is produced from using fat for fuel relative to using carbohydrate. Hormones of metabolic control are affected at the level of production and action.  
CO2 It is often taught that CO2 is a by-product, or even a waste product, of cellular respiration. Although it is true that CO2 is largely exhaled in the breath, and that inhaling pure CO2 is lethal, it does not follow that CO2 is physiologically unnecessary or without benefit. At the molecular level, CO2 is necessary for respiration through its displacement of O2 on hemoglobin [17]. At the tissue level, CO2 relaxes the smooth muscle around vessels, allowing for dilation [18]. In hypocapnic (low blood CO2) conditions, the nitric oxide system, which inhibits respiratory enzymes [19], is mobilized to ensure dilation [20].  These effects are characteristic of acute clinical hypocapnia, but subclinical capnic differences have physiological effects as well. During sleep, for example, hypercapnia increases neuronal oxygenation [21]. Additionally, the rate of Vitamin K dependent carboxylation reactions is determined by CO2 concentration [22]. Furthermore, abundant intra and extracellular CO2 is protective for proteins and lipids susceptible to oxidation. The relatively unreactive oxygen in CO2 transiently associates with amide bonds in proteins, which in sufficient concentrations crowds out reactive oxygen and lowers peroxidation [23,24]. Lastly, CO2 exiting the cell takes with it H2O through a dynamic equilibrium with H2CO3 in aqueous solution [25], lowering cellular bulk water. By removing bulk water, the stoichiometric equilibrium of ADP and ATP is pushed towards ATP. This function of CO2 production may play a large part in the insufficiently explained large increase in ATP synthesis of eukaryotic over prokaryotic enzyme systems, as the motive force of a mitochondrial proton gradient is untenable [26]. It can be concluded that within physiological levels, higher CO2 has benefits, and a higher ratio of carbohydrate to fat being oxidized for fuel yields greater CO2.  
Thyroid Hormone A molecule inextricably related to cellular CO2 production is thyroid hormone (triiodothyronine, T3). T3 is required to produce, among other things, the sex steroids [27] and vitamin A from beta-carotene [28]. Metabolic rate and T3 levels 
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are nearly synonymous, and exert long-term control of heart rate [29] and heat production [30]. During metabolic dysregulation, or acute stress, epinephrine and norepinephrine become more involved in heart rate [31] and body temperature [32], in a similar phenomenon to energy substrate mobilization during stress described above. Despite the name of the thyroid gland, most of the body’s T3 is produced in the liver by converting the prohormone tyrosine to T3. This production is dependent on liver glucose and glycogen [33] and enhanced through an insulin-suppressive action on paraventricular neuropeptide y secretion [34]. Additionally, hypoglycemia-induced glucocorticoids oppose T3 production [35]. Clinically, a calorie restricted, low carb diet causes a similar depression of T3 as starvation, which is not seen in calorie restricted carbohydrate feeding [36]. Thus a low carbohydrate diet appears to be a T3 suppressive diet.  
Insulin Resistance One of the more understood areas of macronutrient physiology is the Randle Cycle, or substrate competition between glucose and fatty acids. At the cellular level, high concentrations of malonyl-CoA from glucose metabolism inhibit the carnitine palmitoyl transferase (CPT) system that shuttles fatty acids towards beta-oxidation. Alternately, high concentrations of acetyl-CoA and citrate from beta-oxidation inhibit the pyruvate dehydrogenase complex (PDHC) that shuttles glucose metabolites towards the Citric Acid Cycle [37]. Thus, there is a tendency to continue using the fuel already in use.  This addresses the misunderstood issue of treating hyperglycemia/insulin resistance/metabolic syndrome by reducing or removing carbohydrate intake. During high-fat diet, total and oxidative glucose disposal is impaired, and pharmacological blockade of fatty acid oxidation reverses this [38]. The reduction of glycemia seen in low carb dieting is not a sign of increased insulin sensitivity, but simply a removal of the challenge. An analogy is the removal of dairy from the lactose intolerants diet; the reduction seen in their symptoms does not reflect an improvement in their ability to handle dairy. A sign of metabolic health is flexibility of use between glucose and fat [39], but even in healthy subjects a fatty acid infusion reduces glucose disposal [40]. Fatty acid oxidation is synonymous with some degree of glucose intolerance.  Not all fatty acids participate in this effect to the same degree. Inhibition of glucose metabolism increases with chain length and degree of unsaturation of fatty acids [41]. This effect is therefore strongest with PUFA. 
 
3) Health implications specific to the polyunsaturated fatty acids (PUFA)   
Breakdown Products and Metabolites In addition to the issues of dietary fat discussed above, PUFA carry the danger of diverse, damaging metabolites. Non-enzymatically, PUFA can be oxidized into peroxides and aldehydes that are likely a key factor in atherosclerotic plaque formation [42,43], as well as damage to cellular contents, such as membrane lipids 
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like mitochondria [44]. Enzymatically, lipooxygenases and peroxidases produce eicosanoids from PUFA, many of which have been shown to have inflammatory effects [45]. The prostaglandins, thromboxanes, and leukotrienes produced from n-3 PUFA are generally considered anti-inflammatory compared to those produced from n-6 PUFA [46]. This anti-inflammatory categorization based on immune activity assays is an example of another action unique to PUFA, that of enzymatic inhibition.  
Proteolytic Inhibition Most of the endocrine activity ascribed to PUFA centers around metabolites, but several purported receptors are hypothesized to accept native PUFA as ligands and alter cell function [47,48]. PUFA alone, for example, can lower circulating LDL [49] and, in the case of n-3, reduce systemic inflammation [50]. How do they accomplish these actions? Conceptually, there are two ways to reduce inflammation, one being to remove the source, as when taking an antibiotic to clear an infection, the second being to inhibit the action of immune cells, reducing markers of inflammation absent addressing the cause. Some evidence points to PUFA working via the latter mechanism.  The LDL lowering effects of PUFA could be caused by inhibition of the proteolytic cleavage of sterol regulatory element-binding protein-1 (SREBP-1) from the cytosolic matrix [51], a similar phenomenon to Tuberculosis bacilli-derived PUFA inhibition of tryptic digestion [52]. The glucuronosyltransferase enzyme, a drug clearance system in the liver, is similarly inhibited in the presence of PUFA [53]. In nature, the most abundant source of PUFA, plant seeds, lay dormant until germination is activated in part by decoupling stored PUFA from their enzymes through water driven H2O2 production [55]. The other significant natural source of PUFA is cold-water fish. These fish use PUFA in order to maintain low viscosity in temperatures approaching the freezing point of water, consequently adapting very low metabolic rates [56].  Plant seeds and cold-water fish have very different metabolisms and physiological needs than mammals. The suppressive actions of PUFA may explain why one of the symptoms of so-called essential fatty acid deficiency is a 25-30% increase in the basal metabolic rate [57]. Thyroid hormone, discussed above as the master metabolic regulator, is blocked at the production [58], transport [59], and cellular action [60] steps by PUFA. If fat, in the context of mammalian systems, is a storage fuel to be used during emergencies, PUFA is an agent by which that system is slowed for preservation over the course of the emergency.  
Conclusion 
 Liberated fatty acids in general, and PUFA in specific, slow the cellular processes of high metabolic rate organisms. Evidence for the effects on thyroid hormone, CO2, insulin action, etc. is here presented, but ultimately “good“ or “bad” vis a vis low carb can only be decided through perspective. Many believe that slowing down the metabolic rate can extend life by reducing wear on the body. This perspective is 
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exemplified in the caloric restriction community. Others believe that the reduction in metabolic rate during aging is a harbinger of decline to be opposed. This could be called the metabolic hypothesis. It is also argued that acute stress and even inflammation is adaptive and beneficial to long-term health. Intermittent fasting puts those ideas into practice. Again, an opposing school of thought advises to eat many small meals throughout the day to avoid the stress response of fasting and support homeostasis.   This article, and the talk it drew from, is an attempt to ground discussion in the first principles of physiology. It is an interesting aspect of the low carb debate that some of the very same phenomena, or perhaps the connotative definitions of them, are seen as good by one side and bad by the other. This shows the futility of the dueling studies approach to debate, as nearly every diet and health paradigm has literature to support it. A lens of perspective must be rigorously applied to this literature and to the claims of its proponents.  Ultimately, health is determined by outcomes rather than inputs, and an agreed-upon definition is required for discussion. I suggest Dr. Michel Accad’s praxeological 
definition of health “as the state that is present when one's physical and mental conditions allow the pursuit of one's chosen ends,” as opposed to the current medical one of “body as machine” that either does or does not currently present defects. Starting from a place of clarity, and moving through evidence with precision, correct conclusions are more likely to be arrived at than through the back 
and forth “gotcha” of the presentation of insufficiently examined information.  
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